ProCE Banner Activity

How I Manage Thyroid Disorders in Cancer Survivors

Clinical Thought
When and how do I manage hypothyroidism after immune checkpoint inhibitors, MIBG treatment, or mitotane, and what is the mechanism of hyperthyroidism in cancer survivors? Read my answers to these questions and more.

Released: April 26, 2021

Expiration: April 25, 2022

No longer available for credit.

Share

Faculty

Steven G. Waguespack

Steven G. Waguespack, MD

Professor
Division of Internal Medicine
Department of Endocrine Neoplasia and Hormonal Disorders
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by the Endocrine Society, in collaboration with Clinical Care Options.
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc

Faculty Disclosure

Primary Author

Steven G. Waguespack, MD

Professor
Division of Internal Medicine
Department of Endocrine Neoplasia and Hormonal Disorders
University of Texas MD Anderson Cancer Center
Houston, Texas

Steven G. Waguespack, MD, has no relevant conflicts of interest to report.